Life Sciences
Across the life sciences sector, organisations are navigating rising development costs, regulatory complexity, new technologies and shifting commercial models. 4C supports clients from early-stage innovators to global biopharma companies, healthcare providers and investors.
Our teams help accelerate delivery, strengthen compliance, build sustainable business models and improve outcomes for patients and consumers.
Big Pharma & Speciality Pharma
Pharmaceutical companies face rising R&D costs, pricing pressures and regulatory hurdles. New players, technologies and business models are reshaping the market. For niche and speciality pharma, these challenges are heightened. Our experts help companies manage costs, secure development partners, and adapt operating models for long-term success.
Small & Emerging Pharma
The shift from an R&D-focused organisation to a fully commercial business brings unique challenges. 4C’s experts help small and emerging pharma companies design sustainable business models, deliver treatments quickly, and meet complex regulatory requirements.
Health, MedTech & Service Providers
Providers face intense competition, complex funding landscapes, and the challenge of scaling while maintaining quality and compliance. We guide organisations through market entry, growth, and operational transformation to improve outcomes and returns. For pharmaceutical service companies, we provide strategies to remain agile, efficient, and competitive.
Private Equity
Life sciences investments require deep sector insight due to long development cycles and high barriers to exit. We help private equity firms optimise EBITDA, unlock growth, and position portfolio companies for strong valuations and profitable exits.